N-(1-(3-acrylamidophenylsulfonyl)piperidin-4-yl)-4-(2,4,6-trifluorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4566167

PubChem CID: 155561117

Max Phase: Preclinical

Molecular Formula: C27H24F6N6O7S

Molecular Weight: 576.56

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(F)cc(F)cc3F)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C25H23F3N6O5S.C2HF3O2/c1-2-21(35)30-16-4-3-5-17(12-16)40(38,39)34-8-6-15(7-9-34)31-25(37)23-20(13-29-33-23)32-24(36)22-18(27)10-14(26)11-19(22)28;3-2(4,5)1(6)7/h2-5,10-13,15H,1,6-9H2,(H,29,33)(H,30,35)(H,31,37)(H,32,36);(H,6,7)

Standard InChI Key:  OTDDRAKRIQKKHH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 47 49  0  0  0  0  0  0  0  0999 V2000
   26.9582  -23.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6659  -22.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2505  -22.8262    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.9582  -24.0520    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.2483  -23.6393    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   28.3736  -23.2348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6659  -22.0090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.0960  -24.8046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.1001  -23.9875    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.3903  -24.3925    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2052  -21.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0224  -21.1562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7966  -20.4485    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7966  -21.8639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9803  -21.8611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5718  -22.5680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9804  -23.2767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8019  -23.2741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2067  -22.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6568  -21.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4310  -20.4506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2482  -20.4485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4987  -19.6706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8362  -19.1919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1764  -19.6741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4740  -21.1562    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2482  -21.8639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8826  -21.8639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4729  -22.5696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8780  -23.2752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6955  -23.2794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1063  -22.5718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6995  -21.8601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9186  -23.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3214  -24.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1379  -24.7072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5500  -24.0005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1397  -23.2889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3246  -23.2890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5434  -25.4167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3606  -25.4202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7662  -26.1296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7722  -24.7142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5834  -26.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5731  -21.1526    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.0239  -22.5631    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.5728  -23.9849    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  9  8  2  0
 10  9  2  0
 11 12  1  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 21  1  0
 22 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 21  2  0
 20 26  1  0
 20 27  2  0
 26 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31  9  1  0
  9 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 36 40  1  0
 40 41  1  0
 41 42  1  0
 41 43  2  0
 42 44  2  0
 15 45  1  0
 19 46  1  0
 17 47  1  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 576.56Molecular Weight (Monoisotopic): 576.1403AlogP: 2.79#Rotatable Bonds: 8
Polar Surface Area: 153.36Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.73CX Basic pKa: 0.01CX LogP: 2.76CX LogD: 2.76
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.30Np Likeness Score: -1.89

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source